• site map

• text size: A- | A+

• : . view text-only
• : . view graphic version

• Research Home
• Neurosciences
• Environmental Toxicology
• Cardiovascular Pharmacology
• Medicinal Chemistry
• Pharmocogenetics
• Cancer Research
• Centers and Facilities

Cardiovascular Pharmacology

Reproductive defects, coronary artery disease, oxidative damage, growth factors in mammalian growth and development, arsenic effects on vasculature, ischemic-reperfusion-injured rat models.

Jerry R. Smith, Associate Professor; Ph.D. (pharmacology), Mississippi, 1977. Cardiovascular pharmacology, drug metabolism and toxicology; development and application of ischemic-reperfusion-injured rat heart models for studying anti-ischemic agents; physiologic/toxicologic implications of nutriceuticals.

J. Douglas Coffin, Professor; Ph.D. (anatomy and cell biology), SUNY Health Sciences Center at Syracuse, 1989. Genetic basis of mammalian growth and development and the function of growth factors in those processes.

Vernon R. Grund, Professor; Ph.D. (pharmacology), Minnesota, 1974. Cardiovascular pharmacology.

Nicholas Natale, Professor; Ph.D. (organic chemistry), Drexel University, 1979. Isoxazoles in medicinal chemistry, especially applied towards potential anti-hypertensive anti-cancer and Alzheimer's therapeutics.

Charles L. Eyer, Professor Emeritus; Ph.D. (pharmacology), Washington State, 1976. Oxidative damage, metal neurotoxicity, cellular responses to stress.